Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ABVC BioPharma, Inc. - Common Stock (NQ:ABVC)

2.750 +0.350 (+14.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 320,002
Open 2.390
Bid (Size) 2.670 (1)
Ask (Size) 2.900 (1)
Prev. Close 2.400
Today's Range 2.390 - 2.770
52wk Range 0.4000 - 5.480
Shares Outstanding 24,420,526
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OncoX Deepens ABVC Alliance
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering
OncoX Deepens ABVC Alliance
Via TheNewswire.com
Topics Initial Public Offering

Performance

YTD
+328.8%
+328.8%
1 Month
-11.3%
-11.3%
3 Month
+161.9%
+161.9%
6 Month
+431.9%
+431.9%
1 Year
+265.7%
+265.7%

More News

Read More
ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma
Via NewMediaWire
ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma
Via TheNewswire.com
ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
Via NewMediaWire
ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
Via TheNewswire.com
ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
Via TheNewswire.com
ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
Via NewMediaWire
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology
Via NewMediaWire
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology
Via TheNewswire.com
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment
Via NewMediaWire
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment
Via TheNewswire.com
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million
Via NewMediaWire
ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million
Via TheNewswire.com
ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value
Via NewMediaWire
ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value
Via TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance
Via NewMediaWire
Topics Artificial Intelligence
ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance
Via TheNewswire.com
Topics Artificial Intelligence
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504
Via NewMediaWire
Topics Intellectual Property
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504
Via TheNewswire.com
Topics Intellectual Property
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan
Via NewMediaWire
Topics Artificial Intelligence Economy
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan
Via TheNewswire.com
Topics Artificial Intelligence Economy

Frequently Asked Questions

Is ABVC BioPharma, Inc. - Common Stock publicly traded?
Yes, ABVC BioPharma, Inc. - Common Stock is publicly traded.
What exchange does ABVC BioPharma, Inc. - Common Stock trade on?
ABVC BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ABVC BioPharma, Inc. - Common Stock?
The ticker symbol for ABVC BioPharma, Inc. - Common Stock is ABVC on the Nasdaq Stock Market
What is the current price of ABVC BioPharma, Inc. - Common Stock?
The current price of ABVC BioPharma, Inc. - Common Stock is 2.750
When was ABVC BioPharma, Inc. - Common Stock last traded?
The last trade of ABVC BioPharma, Inc. - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of ABVC BioPharma, Inc. - Common Stock?
The market capitalization of ABVC BioPharma, Inc. - Common Stock is 67.16M
How many shares of ABVC BioPharma, Inc. - Common Stock are outstanding?
ABVC BioPharma, Inc. - Common Stock has 67M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.